ID: ALA5269900

Max Phase: Preclinical

Molecular Formula: C18H13NO3

Molecular Weight: 291.31

Associated Items:

Representations

Canonical SMILES:  COc1ccc2ccn(-c3cc(=O)c4ccccc4o3)c2c1

Standard InChI:  InChI=1S/C18H13NO3/c1-21-13-7-6-12-8-9-19(15(12)10-13)18-11-16(20)14-4-2-3-5-17(14)22-18/h2-11H,1H3

Standard InChI Key:  KHDXDECWYDHLIO-UHFFFAOYSA-N

Associated Targets(Human)

Monoamine oxidase B 8835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 291.31Molecular Weight (Monoisotopic): 291.0895AlogP: 3.75#Rotatable Bonds: 2
Polar Surface Area: 44.37Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.93CX LogD: 3.93
Aromatic Rings: 4Heavy Atoms: 22QED Weighted: 0.56Np Likeness Score: -0.26

References

1. Madhav H, Jameel E, Rehan M, Hoda N..  (2022)  Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.,  13  (3.0): [PMID:35434628] [10.1039/d1md00394a]

Source